As cancer treatments become more effective, an increasing number of patients are surviving long-term. However, this success has led to a rise in cases of treatment-related secondary leukemia.
Research published on June 8, 2026, indicates that a newly discovered peptide may play a crucial role in blocking DNA breaks that are linked to this form of leukemia.
This development could pave the way for new preventative strategies for cancer survivors, potentially reducing the incidence of secondary leukemia in the future.